Human Organoids Market Outlook:
Human Organoids Market size was over USD 1.15 billion in 2025 and is poised to exceed USD 6.28 billion by 2035, witnessing over 18.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of human organoids is evaluated at USD 1.34 billion.
The market growth can be attributed to the rising incidence of infectious diseases worldwide. According to the Texas Biomedical Research Institute, infectious diseases kill more than 17 million people every year, and 30 new diseases have emerged in the last 20 years. Organoids are proven to be transformative novel tools for the study of human infectious diseases. For instance, lung organoids have been utilized to study respiratory viral infections such as SARS-CoV-2. Researchers are extensively using organoids to study mechanisms of diseases acting within human tissues.
Additionally, the rising demand for biobanking and tumor modeling is expected to propel market growth during the assessed time. According to the Orfonline Research Observation report, there were 340 operational biobanks present globally in 2023. Tumor organoid biobanks are considered to be a new platform for medical research. Also, the biobank of organoids allows scientists to gain access to standardized protocols for the fabrication of human organoids. Human organoids may also be deployed for the customization of therapy or personalized medicine.
